SXC Health Solutions refiles certain Canadian GAAP reconciliations



    
    /NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR
    DISSEMINATION IN THE UNITED STATES/
    

    LISLE, IL, Aug. 11 /CNW/ - SXC Health Solutions Corp. ("SXC" or the
"Company") NASDAQ:   SXCI, TSX: SXC), in connection with the filing of a
preliminary short form base shelf prospectus in each of the provinces of
Canada and the filing of a Form S-3 registration statement with the United
States Securities and Exchange Commission, yesterday filed amended and
restated versions of the Supplemental Financial Information containing the
Reconciliation of Significant Differences Between Accounting Principles
Generally Accepted in the United States and Canada previously filed with its
unaudited interim financial statements as at and for the six month period
ended June 30, 2008 and as at and for the three month period ended March 31,
2009. The purpose of the refiling of these reconciliations was to ensure that
the reconciliations incorporated by reference into the preliminary short form
base shelf prospectus have been prepared on the same basis as those of the
relevant comparative periods. No changes were made to the related financial
statements or accompanying MD&A. SXC also re-filed the reconciliation in
respect of its recently filed unaudited interim financial statements as at and
for the six month period ended June 30, 2009 to provide additional disclosure
regarding recently adopted accounting standards.

    About SXC Health Solutions Corp.

    SXC Health Solutions Corp. is a leading provider of pharmacy benefit
management (PBM) services and Healthcare Information Technology (HCIT)
solutions to the healthcare benefits management industry. As the industry's
"Technology-Enabled PBM"(TM), SXC's product offerings and solutions combine a
wide range of advanced PBM services, software applications, application
service provider (ASP) processing services, and professional services to help
healthcare organizations reduce the cost of prescription drugs and deliver
better healthcare to their members. SXC serves many of the largest
organizations in the pharmaceutical supply chain, such as health plans;
employers; Federal, provincial, and state governments; institutional
pharmacies; pharmacy benefit managers; and retail pharmacy chains. SXC is
headquartered in Lisle, Illinois with multiple locations in North America.
Learn more at www.sxc.com.

    Forward-Looking Statements

    Certain statements included herein, including those that express
management's expectations or estimates of our future performance, constitute
"forward-looking statements" within the meaning of applicable securities laws.
Forward-looking statements are necessarily based upon a number of estimates
and assumptions that, while considered reasonable by management at this time,
are inherently subject to significant business, economic and competitive
uncertainties and contingencies. We caution that such forward-looking
statements involve known and unknown risks, uncertainties and other risks that
may cause our actual financial results, performance, or achievements to be
materially different from our estimated future results, performance or
achievements expressed or implied by those forward-looking statements.
Numerous factors could cause actual results to differ materially from those in
the forward-looking statements, including without limitation, our ability to
achieve increased market acceptance for our product offerings and penetrate
new markets; consolidation in the healthcare industry; the existence of
undetected errors or similar problems in our software products; our ability to
identify and complete acquisitions, manage our growth and integrate
acquisitions; our ability to compete successfully; potential liability for the
use of incorrect or incomplete data; the length of the sales cycle for our
healthcare software solutions; interruption of our operations due to outside
sources; our dependence on key customers; maintaining our intellectual
property rights and litigation involving intellectual property rights; our
ability to obtain, use or successfully integrate third-party licensed
technology; compliance with existing laws, regulations and industry
initiatives and future change in laws or regulations in the healthcare
industry; breach of our security by third parties; our dependence on the
expertise of our key personnel; our access to sufficient capital to fund our
future requirements; and potential write-offs of goodwill or other intangible
assets. This list is not exhaustive of the factors that may affect any of our
forward-looking statements. Other factors that should be considered are
discussed from time to time in SXC 's filings with the U.S. Securities and
Exchange Commission, including the risks and uncertainties discussed under
that captions "Risk Factors" and "Management's Discussion and Analysis of
Financial Condition and Results of Operations" in our 2008 Annual Report on
Form 10-K and subsequent Form 10-Qs, which are available at www.sec.gov.
Investors are cautioned not to put undue reliance on forward-looking
statements. All subsequent written and oral forward-looking statements
attributable to SXC or persons acting on our behalf are expressly qualified in
their entirety by this notice. We disclaim any intent or obligation to update
publicly these forward-looking statements, whether as a result of new
information, future events or otherwise.
    Certain of the assumptions made in preparing forward-looking information
and management's expectations include: maintenance of our existing customers
and contracts, our ability to market our products successfully to anticipated
customers, the impact of increasing competition, the growth of prescription
drug utilization rates at predicted levels, the retention of our key
personnel, our customers continuing to process transactions at historical
levels, that our systems will not be interrupted for any significant period of
time, that our products will perform free of major errors, our ability to
obtain financing on acceptable terms and that there will be no significant
changes in the regulation of our business.

    %SEDAR: 00001439E




For further information:

For further information: Jeff Park, Chief Financial Officer, SXC Health
Solutions, Inc., Tel: (630) 577-3100, investors@sxc.com; Dave Mason, Investor
Relations - Canada, The Equicom Group Inc., (416) 815-0700 ext. 237,
dmason@equicomgroup.com; Susan Noonan, Investor Relation - US, The SAN Group,
LLC, (212) 966-3650, susan@sanoonan.com

Organization Profile

Catamaran

More on this organization


Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890